SP
TNGX icon

SmartHarvest Portfolios’s Tango Therapeutics TNGX Stock Holding History

SmartHarvest Portfolios’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Hold
46,369
– – 0.47% 37
2026
Q1 		$970K Buy
46,369
+246
+0.5% +$3.42K 0.4% 43
2025
Q4 		$409K Buy
+46,123
New +$397K 0.14% 154

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SmartHarvest Portfolios's TNGX Position: Q2 2026 in Review

SmartHarvest Portfolios held its Tango Therapeutics (TNGX) position steady in Q2 2026 at 46,369 shares worth $1.45M. The position accounts for 0.47% of the portfolio, ranked #37.

SmartHarvest Portfolios first reported a position in TNGX in Q4 2025 and has held it in 3 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • SmartHarvest Portfolios held 46,369 shares of Tango Therapeutics worth $1.45M as of Q2 2026.
  • SmartHarvest Portfolios left its Tango Therapeutics share count unchanged in Q2 2026.
  • Tango Therapeutics made up 0.47% of SmartHarvest Portfolios's portfolio in Q2 2026, its #37 holding.
  • SmartHarvest Portfolios first reported a position in Tango Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on SmartHarvest Portfolios's 13F filing for Q2 2026, filed 4 Aug 2026.